Westney Gloria, Foreman Marilyn G, Xu Junjun, Henriques King Marshaleen, Flenaugh Eric, Rust George
Pulmonary and Critical Care Division, Morehouse School of Medicine, Atlanta, Georgia.
Pulmonary and Critical Care Division, Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA 30080. Email:
Prev Chronic Dis. 2017 Apr 13;14:E31. doi: 10.5888/pcd14.160333.
Multimorbidity, the presence of 2 or more chronic conditions, frequently affects people with chronic obstructive pulmonary disease (COPD). Many have high-cost, highly complex conditions that have a substantial impact on state Medicaid programs. We quantified the cost of Medicaid-insured patients with COPD co-diagnosed with other chronic disorders.
We used nationally representative Medicaid claims data to analyze the impact of comorbidities (other chronic conditions) on the disease burden, emergency department (ED) use, hospitalizations, and total health care costs among 291,978 adult COPD patients. We measured the prevalence of common conditions and their influence on COPD-related and non-COPD-related resource use by using the Elixhauser Comorbidity Index. Elixhauser comorbidity counts were clustered from 0 to 7 or more. We performed multivariable logistic regression to determine the odds of ED visits by Elixhauser scores adjusting for age, sex, race/ethnicity, and residence.
Acute care, hospital bed days, and total Medicaid-reimbursed costs increased as the number of comorbidities increased. ED visits unrelated to COPD were more common than visits for COPD, especially in patients self-identified as black or African American (designated black). Hypertension, diabetes, affective disorders, hyperlipidemia, and asthma were the most prevalent comorbid disorders. Substance abuse, congestive heart failure, and asthma were commonly associated with ED visits for COPD. Female sex was associated with COPD-related and non-COPD-related ED visits.
Comorbidities markedly increased health services use among people with COPD insured with Medicaid, although ED visits in this study were predominantly unrelated to COPD. Achieving excellence in clinical practice with optimal clinical and economic outcomes requires a whole-person approach to the patient and a multidisciplinary health care team.
多病共存,即存在两种或更多种慢性病,经常影响慢性阻塞性肺疾病(COPD)患者。许多患者患有高成本、高度复杂的疾病,对州医疗补助计划产生重大影响。我们对患有慢性阻塞性肺疾病并同时被诊断出患有其他慢性疾病的医疗补助参保患者的费用进行了量化。
我们使用具有全国代表性的医疗补助索赔数据,分析了291,978名成年慢性阻塞性肺疾病患者中合并症(其他慢性病)对疾病负担、急诊科(ED)就诊、住院情况和总医疗费用的影响。我们使用埃利克斯豪泽合并症指数来衡量常见疾病的患病率及其对慢性阻塞性肺疾病相关和非慢性阻塞性肺疾病相关资源利用的影响。埃利克斯豪泽合并症计数从0到7或更多进行分组。我们进行了多变量逻辑回归,以确定根据埃利克斯豪泽评分调整年龄、性别、种族/族裔和居住地后急诊科就诊的几率。
随着合并症数量的增加,急性护理、住院天数和医疗补助报销的总费用也增加。与慢性阻塞性肺疾病无关的急诊科就诊比慢性阻塞性肺疾病相关就诊更为常见,尤其是在自我认定为黑人或非裔美国人(指定为黑人)的患者中。高血压、糖尿病、情感障碍、高脂血症和哮喘是最常见的合并症。药物滥用、充血性心力衰竭和哮喘通常与慢性阻塞性肺疾病的急诊科就诊有关。女性与慢性阻塞性肺疾病相关和非慢性阻塞性肺疾病相关的急诊科就诊有关。
合并症显著增加了参加医疗补助的慢性阻塞性肺疾病患者的医疗服务使用,尽管本研究中的急诊科就诊主要与慢性阻塞性肺疾病无关。要实现具有最佳临床和经济结果的卓越临床实践,需要对患者采取全人方法,并组建多学科医疗团队。